|
|
| | 6-Amino-2,2-dimethyl-2H-pyrido[3,2-B][1,4]oxazin-3(4H)-one Basic information |
| Product Name: | 6-Amino-2,2-dimethyl-2H-pyrido[3,2-B][1,4]oxazin-3(4H)-one | | Synonyms: | 6-AMINO-2,2-DIMETHYL-2H-PYRIDO[3,2-B][1,4]OXAZIN-3(4H)-ONE;6-AMino-2,2-diMethyl-2H-p...;6-Amino-2,2-dimethyl-2H-pyrido[3,2-b][1,4]oxazin-3(4H);2H-Pyrido[3,2-b]-1,4-oxazin-3(4H)-one, 6-aMino-2,2-diMethyl-;6-Amino-2,2-dimethyl-2H-pyrido[3,2-b][1,4]oxazin-3;1002726-62-6 6-AMINO-2,2-DIMETHYL-2H-PYRIDO[3,2-B][1,4]OXAZIN-3(4H)-ONE;6-amino-2,2-dimethyl-2H,3H,4H-pyrido[3,2-b][1,4]oxazin-3-one | | CAS: | 1002726-62-6 | | MF: | C9H11N3O2 | | MW: | 193.2 | | EINECS: | | | Product Categories: | | | Mol File: | 1002726-62-6.mol | ![6-Amino-2,2-dimethyl-2H-pyrido[3,2-B][1,4]oxazin-3(4H)-one Structure](CAS2/GIF/1002726-62-6.gif) |
| | 6-Amino-2,2-dimethyl-2H-pyrido[3,2-B][1,4]oxazin-3(4H)-one Chemical Properties |
| Boiling point | 420.3±45.0 °C(Predicted) | | density | 1.256 | | Fp | 208 | | storage temp. | 2-8°C(protect from light) | | pka | 10.79±0.40(Predicted) | | form | solid | | form | solid | | Appearance | White to off-white Powder | | InChI | InChI=1S/C9H11N3O2/c1-9(2)8(13)12-7-5(14-9)3-4-6(10)11-7/h3-4H,1-2H3,(H3,10,11,12,13) | | InChIKey | HSYOWUOUDXDSMC-UHFFFAOYSA-N | | SMILES | O1C(C)(C)C(=O)NC2=NC(N)=CC=C12 |
| | 6-Amino-2,2-dimethyl-2H-pyrido[3,2-B][1,4]oxazin-3(4H)-one Usage And Synthesis |
| Uses | 6-Amino-2,2-dimethyl-2H-pyrido[3,2-b][1,4]oxazin-3(4H)-one is a useful intermediate for the preparation of protein kinase inhibitors. | | Application | 6-amino-2,2-dimethyl-2h-pyrido[3,2-b][1,4]oxazin-3(4h)-one is the key intermediate of Fostamatinib, which is a medication approved by the U.S. Food and Drug Administration since 2018 for the treatment of chronic immune thrombocytopenia (ITP). |
| | 6-Amino-2,2-dimethyl-2H-pyrido[3,2-B][1,4]oxazin-3(4H)-one Preparation Products And Raw materials |
|